Related Experiment Video
Updated: May 17, 2026
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Future classes of hepatitis C virus therapeutic agents
Jennifer Y Chen1, Raymond T Chung
1GI Unit, Massachusetts General Hospital, GRJ724, 55 Fruit Street, Boston, MA 02114, USA.
Infectious Disease Clinics of North America
|October 23, 2012
Summary
Novel hepatitis C virus therapeutics, including direct-acting and host-targeted antivirals, offer shorter, safer, and interferon-free treatment options. This review details their mechanisms, efficacy, and side effects.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection is a major global health concern.
- Understanding HCV molecular characteristics has driven therapeutic innovation.
- Current treatments aim for improved efficacy and reduced toxicity.
Purpose of the Study:
- To review novel hepatitis C virus therapeutics currently in development.
- To discuss the mechanisms of action for direct-acting and host-targeted antivirals.
- To summarize the efficacy and adverse effect profiles of these emerging agents.
Main Methods:
- Literature review of recent scientific publications and clinical trial data.
- Analysis of novel antiviral agents targeting specific viral or host factors.
- Synthesis of information on drug classes, efficacy, and safety.
Main Results:
- Multiple classes of direct-acting antivirals (DAAs) and host-targeted antivirals (HTAs) are under investigation.
- These novel agents show promise for shorter treatment durations.
- Potential for improved side effect profiles and interferon-sparing regimens.
Conclusions:
- Emerging hepatitis C virus therapeutics represent a significant advancement in treatment.
- DAAs and HTAs offer a pathway to more effective and tolerable HCV eradication.
- Further research and clinical trials are essential to optimize their use.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...